The AXL receptor tyrosine kinase is a protein encoded by the AXL gene. Functioning as a membrane-spanning receptor, it primarily binds with its ligand, Gas6, to regulate various cellular processes, including survival, proliferation, and migration. Often linked to signal transduction pathways, AXL acts as a pivotal interface between extracellular signals and intracellular responses. Upon ligand binding, AXL activates several downstream pathways, including PI3K-AKT, MAPK, and JAK-STAT, among others. These pathways orchestrate an array of cellular functions, thereby giving AXL a crucial role in physiological as well as cellular responses to environmental cues. For instance, AXL activation can modulate anti-inflammatory responses, influence cell survival mechanisms, and regulate cellular adhesion and movement. Although its specific roles can vary depending on the cellular context, the activation of AXL generally results in a coordinated output that serves to adapt or respond to specific environmental conditions or stimuli.
The term Axl Activators refers to a set of chemical compounds capable of modulating the activity of the AXL receptor tyrosine kinase. This class of chemicals doesn't necessarily include direct activators of AXL but largely focuses on indirect means of elevating its activity. Such compounds interact with diverse signaling pathways, leading to subsequent AXL activation as a secondary or compensatory mechanism. For example, inhibitors targeting parallel or competing signaling pathways, such as PI3K, Src family kinases, or mTOR, can prompt cells to upregulate AXL activity as an alternative route for signal transduction. Additionally, certain growth factors like EGF and VEGF are capable of transactivating AXL through their primary receptors, thereby broadening the scope of chemicals that can effectively lead to AXL activation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, thereby inducing compensatory AXL activation. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Inhibits Src family kinases, leading to upregulation and activation of AXL. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Can activate AXL through its signaling cascade. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
CDK4/6 inhibitor that can lead to AXL activation as a resistance mechanism. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor known to trigger AXL activation as a bypass route. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
Inhibits JAK-STAT signaling, leading to compensatory AXL activation. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Abl kinase inhibitor that can result in AXL activation. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Known to modulate AXL activation indirectly through anti-inflammatory pathways. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Affects multiple pathways that may result in increased AXL activation. | ||||||